Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01281293 · ClinicalTrials.gov registry record
Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated
A clinical trial, sponsored by Cyberonics.
- Completed
- Registry status
- 124
- Enrollment target
NCT01281293 is a clinical trial that has completed, run by Cyberonics. The registered enrollment target is 124 participants.
The verdict
NCT01281293 has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
Vagus Nerve Stimulation (VNS) Therapy has been approved marked for the treatment of epilepsy since 1994. This post-market study is designed to follow the clinical course and outcomes for patients with refractory seizures treated with adjunctive VNS Therapy. Seizure frequency, seizure severity, side effects burden, depressive symptoms, global impressions, and health care utilization will be evaluated. The results of this study will provide data to guide physicians and their patients in the use of VNS Therapy for patients with refractory seizures who have failed initial trials of anti-epileptic drug (AED) therapy. The data being collected is not for the purposes of confirmatory assessment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2011-01 |
| Est. Completion | 2018-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01281293
The ClinicalTrials.gov registry entry for NCT01281293 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cyberonics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01281293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01281293 about?
NCT01281293 is a clinical study titled "Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated". Vagus Nerve Stimulation (VNS) Therapy has been approved marked for the treatment of epilepsy since 1994. This post-market study is designed to follow the clinical course and outcomes for patients with refractory seizures treated with adjunctive VNS Therapy. Seizure frequency, seizure severity, side ...
What is the current status of trial NCT01281293?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2011-01. Estimated completion is 2018-08-16.
Who is sponsoring clinical trial NCT01281293?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.